VSIQQ Trademark
Trademark Overview
On Thursday, October 2, 2014, a trademark application was filed for VSIQQ with the United States Patent and Trademark Office. The USPTO has given the VSIQQ trademark a serial number of 79156527. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Wednesday, October 2, 2024. This trademark is owned by NOVARTIS AG. The VSIQQ trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-inf...
General Information
| Serial Number | 79156527 |
| Word Mark | VSIQQ |
| Filing Date | Thursday, October 2, 2014 |
| Status | 404 - IR CANCELLED - US REGISTRATION CANCELLED |
| Status Date | Wednesday, October 2, 2024 |
| Registration Number | 4741443 |
| Registration Date | Tuesday, May 26, 2015 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 10, 2015 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-infective, antiviral preparations and antibiotics |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | H - NOT AVAILABLE |
| Class Status Date | Tuesday, June 1, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | NOVARTIS AG |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | CH |
| Party Name | NOVARTIS AG |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | CH |
| Party Name | NOVARTIS AG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | CH |
Trademark Events
| Event Date | Event Description |
| Tuesday, May 26, 2015 | REGISTERED-PRINCIPAL REGISTER |
| Thursday, December 11, 2014 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Tuesday, December 16, 2014 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, December 20, 2014 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, January 21, 2015 | ASSIGNED TO EXAMINER |
| Tuesday, January 27, 2015 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, February 18, 2015 | NOTICE OF PUBLICATION |
| Tuesday, March 10, 2015 | PUBLISHED FOR OPPOSITION |
| Sunday, December 12, 2021 | REFUSAL PROCESSED BY IB |
| Monday, April 21, 2025 | DEATH OF INTERNATIONAL REGISTRATION |
| Tuesday, December 27, 2022 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Thursday, June 25, 2015 | GRANT OF PROTECTION CREATED, TO BE SENT TO IB |
| Thursday, August 6, 2015 | FINAL DISPOSITION PROCESSED |
| Thursday, August 6, 2015 | FINAL DISPOSITION NOTICE SENT TO IB |
| Friday, August 21, 2015 | NOTIFICATION PROCESSED BY IB |
| Saturday, June 19, 2021 | DEATH OF INTERNATIONAL REGISTRATION |
| Saturday, June 19, 2021 | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED |
